Fooderapy è una startup innovativa di healthy food il cui obiettivo è quello di offrire a domicilio pasti sani e mirati alle esigenze di ognuno, grazie al lavoro di dietologi specialisti in collaborazione con chef esperti. Il progetto nasce dall’evidenza, ormai...
PaoloGiove
Maria Rescigno e il libro per imparare a conoscere il microbiota
“Microbiota, arma segreta del sistema immunitario. Conoscere e prendersi cura del miglior amico della nostra salute” è il nuovo libro scritto dalla Prof.ssa Maria Rescigno, Responsabile dell'Unità di Immunologia Mucosa e Microbiota dell'Ospedale e Università Humanitas...
Effetto dei postbiotici sulla barriera epiteliale intestinale: nuove evidenze
Si è tenuta a Vienna dal 28 al 30 aprile la terza edizione del World of Microbiome Conference, congresso internazionale dedicato allo studio e alla ricerca nell’ambito del microbioma. La conferenza è stata animata da un ampio panel di professionisti nel campo della...
“Microbiota, arma segreta del sistema immunitario. Conoscere e prendersi cura del miglior amico della nostra salute” is the new book written by Prof. Maria Rescigno.
The new book "Microbiota, arma segreta del il sistema immunitario. Conoscere e prendersi cura del miglior amico della nostra salute", written by Prof. Maria Rescigno, Head of Mucosal Immunology and Microbiota Unit of Humanitas Hospital and University, has recently...
The project “L’onda Covid: capire per reagire” interviews Prof. Maria Rescigno on the immunity to SARS-CoV-2
The project “L’onda Covid: capire per reagire”, a cycle of conferences with internationally renowned Italian scientists coordinated by the magazine of the University of Padova “Il Bo Live” to approach the Genoa Science Festival, hosted Prof. Maria Rescigno, Head of...
A new article of the Lab. Mucosal Immunology and Microbiota will be published: “The Microbiome of Catheter-Collected Urine in Males with Bladder Cancer according to Disease Stage”.
The work of the Mucosal and Microbiota Immunology Laboratory directed by Prof. Maria Rescigno at Humanitas Research Hospital will be published in The Journal Of Urology. The dogma that urine is sterile has been overturned and dysbiosis of the urinary microbiome has...
Will fermented foods, such as kefir and miso, be the protagonists of the food of the future?
Our Founder, Prof. Maria Rescigno, Head of Mucosal Immunology and Microbiota Unit of Humanitas Hospital and University, releases an interview to journalist Eliana Liotta within the program: ‘Health, the word to female scientists’. ...
I Dialoghi di Medical Facts – Resident Bacteria, Obesity, Cancer and More.
What are prebiotics, probiotics and postbiotics? Our Founder Prof. Maria Rescigno, one of the world's leading experts on the subject, speaks. ...
A new manuscript of the Laboratory of Mucosal Immunology and Microbiota published in “Nature Microbiology” against the development of intestinal tumors.
The work of the Mucosal and Microbiota Immunology Laboratory directed by Prof. Maria Rescigno at Humanitas Research Hospital and supported by the AIRC foundation, led to the publication in Nature Microbiology of the paper regarding the identification of endogenous...
Innovation at the 25th IFSCC congress: postbiotics for healthy skin and microbiota.
The 25th edition of the Ifscc conference, an international event dedicated to cosmetological sciences promoted by the International Federation of Chemical Products Companies, has witnessed two important contributions by our company. Postbiotica, represented by the...
Postbiotica signs a worldwide licensing agreement with Kalichem to promote postbiotic-based products in the medical device and dermocosmetic area.
Postbiotica has signed a licensing agreement with Kalichem(a Lamberti company) leader in the dermocosmetic market, based on a well established R&D collaboration. Kalichem develops and commercializes functional ingredients for cosmetics and medical devices. The...
Postbiotica signs a worldwide licensing agreement with Candioli to boost postbiotic-based nutraceuticals in the pet-care area
Postbiotica has signed a licensing and commercialising agreement with Candioli Pharma, a company leader in the pet-care market. The agreement foresees the exclusivity of the postbiotic ImmunoFOS® as an active ingredient to develop innovative nutraceuticals for pet...
Postbiotics represent an innovative therapeutic approach to prevent NEC
Necrotizing enterocolitis (NEC) primarily affects premature newborns, occurring in 7–10% of very low birth weight infants, from 2 weeks to 2 months of age, with an incidence inversely related to gestational age (Patel et al. 2015). It is associated with a mortality as...
The liver-gut axis: how the Dysbiosis is involved in NAFLD and NASH.
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of cardiometabolic syndrome, which often also includes obesity, diabetes, and dyslipidemia. It is rapidly becoming the most prevalent liver disease worldwide. A sizable minority of NAFLD patients...
Postbiotics: the new bioactive compounds.
Gut bacteria depend fully on their host to provide the necessary nutrients that may promote microbiota growth. However, bacteria produce small molecular weight metabolites during their lifecycle; these compounds play a key role in regulating self-growth, development,...
Healthy Gut Microbiota for living healthy life
The human gut is the habitat to trillions of microbial cells with over 1,000 diverse microbial species that contribute to the primary functions of the gastrointestinal tract, including nutrition and defense. On the other hand, the gastrointestinal tract mucosa...
MyStartBCN: a big victory for Postbiotica
Postbiotica, represented by Francesca Algieri, won the first edition of the My Start BCN contest and has been rewarded by the President of the Chamber of Commerce, Igor Garzesi. Postbiotica has impressed the jury for the development of new metabolities derivated from...
Postbiotica wins BIOUPPER
Postbiotica has presented the new technology to modulate the production of bacterial metabolites, called Postbiotics. Postbiotica has been selected among 151 projects by Bioupper. Bioupper is a training and acceleration platform and converts and enhances he best ideas...
From research to business
Maria Rescigno, professor and entrepreneur, co-founder of POSTBIOTICA, an innovative biopharmaceutical StartUp winner of the "MYSTART BCN" competition, is interviewed by "Italiani Anywhere".